advanced gastric adenocarcinoma

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Advanced Gastric Adenocarcinoma Trial in Henan (camrelizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Henan, China
    Henan Tumor Hospital
Oct 13, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Advanced Gastric Adenocarcinoma Trial in Ho-nan (Camrelizumab, Albumin-bound paclitaxel, S-1)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Camrelizumab, Albumin-bound paclitaxel, S-1
  • Ho-nan, Henan, China
    Henan Tumor Hospital
Apr 14, 2022

Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8

Recruiting
  • Advanced Gastric Adenocarcinoma
  • +32 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 2, 2022

Advanced Gastric Adenocarcinoma Trial in Baltimore (Paclitaxel, Olaparib, Pembrolizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Immunotherapy
  • EV-array
  • Beijing, China
    Peking University Cancer Hospital & Institute
Aug 5, 2021

Advanced Gastric Adenocarcinoma Trial in Xuzhou (LY011)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • LY011
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 23, 2021

Advanced Gastric Adenocarcinoma Trial in Seoul (GSK2636771, Paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Apr 21, 2021

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, Docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Dec 26, 2019

Advanced Gastric Adenocarcinoma Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, POF)

Unknown status
  • Advanced Gastric Adenocarcinoma
  • Fuzhou, China
    Rongbo Lin
Nov 21, 2019

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)

Terminated
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
May 17, 2019

Advanced Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Shanghai (CAR-CLD18 T Cells)

Unknown status
  • Advanced Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • CAR-CLD18 T Cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2018

Advanced Gastric Adenocarcinoma Trial in Guangzhou (D2 lymphadenectomy, Systemic chemo, HIPEC)

Unknown status
  • Advanced Gastric Adenocarcinoma
  • D2 lymphadenectomy
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Abdominal Surgery (Section 2), Affiliated Tumor Ho
Sep 12, 2014